STAT3 and hepatocellular carcinoma: Such effects were also proposed to be achieved by the OC-induced inhibition of the STAT3-dependent pathway, which was shown to result in reduced proliferation, epithelial–mesenchymal transition, migration and invasiveness and enhanced apoptosis in hepatocellular carcinoma cells as well as in an orthotopically implanted experimental HCC [53].